Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy
Purpose
This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future
Conditions
- Cancer Screening
- Transgender
- Gender Diverse Populations
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- 18 years and older - Able to provide voluntary written consent prior to the performance of any research related activity. Patients who can provide informed consent - Able to understand, speak, read, and write in English - Patients who have undergone hysterectomy, or plan to have a hysterectomy - Patients who are transgender and gender diverse"
Exclusion Criteria
- Opted out of research - <18 years old - Lacks capacity to consent/has diminished capacity to consent - Cannot provide informed consent - Those on the study's community advisory board
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| Standard of Care Cancer Screening |
|
|
| FDA approved self swab |
|
|
| Mock self swab |
|
Recruiting Locations
University of Minnesota
Minneota, Minnesota 55455
Minneota, Minnesota 55455
More Details
- Status
- Recruiting
- Sponsor
- University of Minnesota